BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 17292824)

  • 21. Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta.
    Solt LA; Madge LA; Orange JS; May MJ
    J Biol Chem; 2007 Mar; 282(12):8724-33. PubMed ID: 17244613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein Kinase-Mediated Decision Between the Life and Death.
    Engin A
    Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR6 protects from inflammation and fibrosis in NEMO
    Liepelt A; Wehr A; Kohlhepp M; Mossanen JC; Kreggenwinkel K; Denecke B; Costa IG; Luedde T; Trautwein C; Tacke F
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):391-402. PubMed ID: 30476545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TAK1: Another mesh in the NF-κB - JNK controlled network causing hepatocellular carcinoma.
    Greten FR
    J Hepatol; 2011 Sep; 55(3):721-723. PubMed ID: 21601601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.
    Beraza N; Ofner-Ziegenfuss L; Ehedego H; Boekschoten M; Bischoff SC; Mueller M; Trauner M; Trautwein C
    Gut; 2011 Mar; 60(3):387-96. PubMed ID: 21115542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress.
    Huang TT; Wuerzberger-Davis SM; Wu ZH; Miyamoto S
    Cell; 2003 Nov; 115(5):565-76. PubMed ID: 14651848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury.
    Ehedego H; Mohs A; Jansen B; Hiththetiya K; Sicinski P; Liedtke C; Trautwein C
    Oncogene; 2018 Jun; 37(25):3329-3339. PubMed ID: 29551768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OTULIN Prevents Liver Inflammation and Hepatocellular Carcinoma by Inhibiting FADD- and RIPK1 Kinase-Mediated Hepatocyte Apoptosis.
    Verboom L; Martens A; Priem D; Hoste E; Sze M; Vikkula H; Van Hove L; Voet S; Roels J; Maelfait J; Bongiovanni L; de Bruin A; Scott CL; Saeys Y; Pasparakis M; Bertrand MJM; van Loo G
    Cell Rep; 2020 Feb; 30(7):2237-2247.e6. PubMed ID: 32075762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer.
    Liedtke C; Trautwein C
    Eur J Cell Biol; 2012; 91(6-7):582-9. PubMed ID: 22153863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NEMO expression in human hepatocellular carcinoma and its association with clinical outcome.
    Aigelsreiter A; Haybaeck J; Schauer S; Kiesslich T; Bettermann K; Griessbacher A; Stojakovic T; Bauernhofer T; Samonigg H; Kornprat P; Lackner C; Pichler M
    Hum Pathol; 2012 Jul; 43(7):1012-9. PubMed ID: 22176836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IKKgamma /NEMO facilitates the recruitment of the IkappaB proteins into the IkappaB kinase complex.
    Yamamoto Y; Kim DW; Kwak YT; Prajapati S; Verma U; Gaynor RB
    J Biol Chem; 2001 Sep; 276(39):36327-36. PubMed ID: 11470788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of Akt/NF-κB-regulated inflammation and Akt/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle.
    Tang B; Tang F; Wang Z; Qi G; Liang X; Li B; Yuan S; Liu J; Yu S; He S
    Int J Nanomedicine; 2016; 11():6401-6420. PubMed ID: 27942213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions.
    Vlantis K; Wullaert A; Polykratis A; Kondylis V; Dannappel M; Schwarzer R; Welz P; Corona T; Walczak H; Weih F; Klein U; Kelliher M; Pasparakis M
    Immunity; 2016 Mar; 44(3):553-567. PubMed ID: 26982364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.
    Li X; Massa PE; Hanidu A; Peet GW; Aro P; Savitt A; Mische S; Li J; Marcu KB
    J Biol Chem; 2002 Nov; 277(47):45129-40. PubMed ID: 12221085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA-PK: gatekeeper for IKKγ/NEMO nucleocytoplasmic shuttling in genotoxic stress-induced NF-kappaB activation.
    Medunjanin S; Putzier M; Nöthen T; Weinert S; Kähne T; Luani B; Zuschratter W; Braun-Dullaeus RC
    Cell Mol Life Sci; 2020 Oct; 77(20):4133-4142. PubMed ID: 31932854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage.
    Wuerzberger-Davis SM; Nakamura Y; Seufzer BJ; Miyamoto S
    Oncogene; 2007 Feb; 26(5):641-51. PubMed ID: 16862178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The reduction of cell death and proliferation by p27(Kip1) minimizes DNA damage in an experimental model of genotoxicity.
    Ranchal I; González R; Bello RI; Ferrín G; Hidalgo AB; Linares CI; Aguilar-Melero P; González-Rubio S; Barrera P; Marchal T; Nakayama KI; de la Mata M; Muntané J
    Int J Cancer; 2009 Nov; 125(10):2270-80. PubMed ID: 19672859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death.
    Lluis JM; Buricchi F; Chiarugi P; Morales A; Fernandez-Checa JC
    Cancer Res; 2007 Aug; 67(15):7368-77. PubMed ID: 17671207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antioxidant amelioration of dilated cardiomyopathy caused by conditional deletion of NEMO/IKKgamma in cardiomyocytes.
    Kratsios P; Huth M; Temmerman L; Salimova E; Al Banchaabouchi M; Sgoifo A; Manghi M; Suzuki K; Rosenthal N; Mourkioti F
    Circ Res; 2010 Jan; 106(1):133-44. PubMed ID: 19850942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-κB activation and leads to incontinentia pigmenti.
    Bal E; Laplantine E; Hamel Y; Dubosclard V; Boisson B; Pescatore A; Picard C; Hadj-Rabia S; Royer G; Steffann J; Bonnefont JP; Ursini VM; Vabres P; Munnich A; Casanova JL; Bodemer C; Weil R; Agou F; Smahi A
    J Allergy Clin Immunol; 2017 Dec; 140(6):1671-1682.e2. PubMed ID: 28249776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.